PASW (Ping An Biomedical Co) LT-Debt-to-Total-Asset: 0.00 (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PASW Ping An Biomedical Co Ltd PASW
17 GF Score
Price $0.12
! 3 Warning Signs
View Full Analysis

What is Ping An Biomedical Co LT-Debt-to-Total-Asset?

Ping An Biomedical Co PASW -6.49% 17 LT-Debt-to-Total-Asset is 0.00 as of Sep. 2025. GuruFocus rates PASW with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Ping An Biomedical Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2025 was 0.00.

Ping An Biomedical Co's long-term debt to total assets ratio declined from Sep. 2024 (0.01) to Sep. 2025 (0.00). It may suggest that Ping An Biomedical Co is progressively becoming less dependent on debt to grow their business.


Ping An Biomedical Co  (NAS:PASW) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Ping An Biomedical Co LT-Debt-to-Total-Asset Related Terms


Ping An Biomedical Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Ping An Biomedical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ping An Biomedical Co LT-Debt-to-Total-Asset Chart

Ping An Biomedical Co Annual Data
Trend Sep21 Sep22 Sep23 Sep24 Sep25
LT-Debt-to-Total-Asset
0.00 0.00 0.00 0.01 0.00

Ping An Biomedical Co Semi-Annual Data
Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only 0.00 0.01 0.01 0.01 0.00
PASW
17GF Score
Ping An Biomedical Co Ltd PASW
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ping An Biomedical Co LT-Debt-to-Total-Asset Calculation

Ping An Biomedical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Sep. 2025 is calculated as

LT Debt to Total Assets (A: Sep. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Sep. 2025 )/Total Assets (A: Sep. 2025 )
=0.013/9.604
=0.00

Ping An Biomedical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2025 is calculated as

LT Debt to Total Assets (Q: Sep. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2025 )/Total Assets (Q: Sep. 2025 )
=0.013/9.604
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Ping An Biomedical Co (PASW) has a LT-Debt-to-Total-Asset of 0.00 as of Sep. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Ping An Biomedical Co and its competitors.
Is Ping An Biomedical Co's LT-Debt-to-Total-Asset too high?
Ping An Biomedical Co's current LT-Debt-to-Total-Asset is 0.00. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's LT-Debt-to-Total-Asset compare to DXYN and CULP?
Ping An Biomedical Co's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Manufacturing - Apparel & Accessories company?
A good LT-Debt-to-Total-Asset depends on the Manufacturing - Apparel & Accessories industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Ping An Biomedical Co and its competitors. Ping An Biomedical Co's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current LT-Debt-to-Total-Asset is 0.00 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ping An Biomedical Co Business Description

Address Tai Nan West Street, 1002-1008, 22nd Floor, China United Plaza, Cheung Sha Wan, Kowloon, Hong Kong, HKG
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score

Get the complete analysis for PASW

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.12
Price